Navidea Biopharmaceuticals, Inc. (NAVB) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 6 Buy, 1 Hold, 1 Sell.
NAVB Analyst Ratings
Buy
8
Ratings
6 Buy
1 Hold
1 Sell
Based on 8 analysts giving stock ratings to Navidea Biopharmaceuticals, Inc. in the past 3 months
